The rate of accumulation of nonnucleoside reverse transcriptase inhibitor (NNRTI) resistance in patients kept on a virologically failing regimen containing an NNRTI*

A Cozzi-Lepri, Paredes, A N Phillips, B Clotet, J Kjaer, V Von Wyl, Gitte Kronborg, A Castagna, J R Bogner, Jens Dilling Lundgren, EuroSIDA in EuroCOORD

25 Citationer (Scopus)

Abstract

Virological failure of first-generation nonnucleoside reverse transcriptase inhibitors (NNRTIs) can compromise the efficacy of etravirine as a result of the accumulation of NNRTI resistance mutations. How quickly NNRTI resistance accumulates in patients with a delayed switch from nevirapine or efavirenz despite virological failure, when these drugs are used as a component of combination antiretroviral therapy (cART), remains unclear.
OriginalsprogEngelsk
TidsskriftHIV Medicine
Vol/bind13
Udgave nummer1
Sider (fra-til)62-72
Antal sider11
DOI
StatusUdgivet - 2012

Fingeraftryk

Dyk ned i forskningsemnerne om 'The rate of accumulation of nonnucleoside reverse transcriptase inhibitor (NNRTI) resistance in patients kept on a virologically failing regimen containing an NNRTI*'. Sammen danner de et unikt fingeraftryk.

Citationsformater